AEST.MED.INT.HLD.SP.ADR/3 Total Liabilities

Latest as of December 2025: €554.12 Million EUR ≈ $647.83 Million USD

AEST.MED.INT.HLD.SP.ADR/3 total liabilities. Based on the latest financial reports, AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has total liabilities worth €554.12 Million EUR (≈ $647.83 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See AEST.MED.INT.HLD.SP.ADR/3 (3FMA) defensive interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)

Total liabilities of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025. This chart illustrates how AEST.MED.INT.HLD.SP.ADR/3's total liabilities have evolved over time, based on quarterly financial data. Explore 3FMA long-term investment intensity to see how much of total assets are deployed in long-term investments.

AEST.MED.INT.HLD.SP.ADR/3 Competitors by Total Liabilities

The table below lists competitors of AEST.MED.INT.HLD.SP.ADR/3 ranked by their total liabilities.

Company	Country	Total Liabilities
60 Degrees Pharmaceuticals, Inc. Common Stock NASDAQ:SXTP	USA	$1.75 Million
WestKam Gold Corp V:WKG	Canada	CA$880.07K
NextEnergy Solar Fund Ltd LSE:NESF	UK	GBX201.29 Million
Azitra Inc NYSE MKT:AZTR	USA	$1.22 Million
Kedaung Indah Can Tbk JK:KICI	Indonesia	Rp100.38 Billion
Marvel Discovery Corp V:MARV	Canada	CA$1.86 Million
Linkage Global Inc NASDAQ:UZX	USA	$5.54 Million
Eagle Pharmaceuticals Inc NASDAQ:EGRX	USA	$152.78 Million

Liability Composition Analysis (2021–2025)

This chart breaks down AEST.MED.INT.HLD.SP.ADR/3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of AEST.MED.INT.HLD.SP.ADR/3.

Liquidity & Leverage Metrics

AEST.MED.INT.HLD.SP.ADR/3 Total Liabilities Ratios Explained

AEST.MED.INT.HLD.SP.ADR/3 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-26.90	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AEST.MED.INT.HLD.SP.ADR/3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)

The table below shows the annual total liabilities of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€554.12 Million ≈ $647.83 Million	+16.20%
2024-12-31	€476.88 Million ≈ $557.52 Million	-9.52%
2023-12-31	€527.03 Million ≈ $616.16 Million	-21.60%
2022-12-31	€672.25 Million ≈ $785.93 Million	-11.94%
2021-12-31	€763.36 Million ≈ $892.45 Million	--

About AEST.MED.INT.HLD.SP.ADR/3

F:3FMA Germany Medical Care Facilities

Market Cap

$3.30 Million

€2.82 Million EUR

Market Cap Rank

#29309 Global

#2538 in Germany

Share Price

€0.06

Change (1 day)

+0.87%

52-Week Range

€0.01 - €0.30

All Time High

€8.75